APA (7th ed.) Citation

Chang, H. P., Shakhnovich, V., Frymoyer, A., Funk, R. S., Becker, M. L., Park, K. T., & Shah, D. K. (2022). A population physiologically‐based pharmacokinetic model to characterize antibody disposition in pediatrics and evaluation of the model using infliximab. British Journal of Clinical Pharmacology, 88(1), 290. https://doi.org/10.1111/bcp.14963

Chicago Style (17th ed.) Citation

Chang, Hsuan Ping, Valentina Shakhnovich, Adam Frymoyer, Ryan Sol Funk, Mara L. Becker, K. T. Park, and Dhaval K. Shah. "A Population Physiologically‐based Pharmacokinetic Model to Characterize Antibody Disposition in Pediatrics and Evaluation of the Model Using Infliximab." British Journal of Clinical Pharmacology 88, no. 1 (2022): 290. https://doi.org/10.1111/bcp.14963.

MLA (9th ed.) Citation

Chang, Hsuan Ping, et al. "A Population Physiologically‐based Pharmacokinetic Model to Characterize Antibody Disposition in Pediatrics and Evaluation of the Model Using Infliximab." British Journal of Clinical Pharmacology, vol. 88, no. 1, 2022, p. 290, https://doi.org/10.1111/bcp.14963.